tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
with an average price target of $7.46. This is a potential upside of $6.16 (473.85%) from yesterday's end of day stock price of $1.3.
Zynerba Pharmaceuticals's activity chart (see below) currently has 71 price targets and 59 ratings on display.
Analysts average stock forecasts to be materialized ratio is 19.07% with an average time for these price targets to be met of 110.33 days.
Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 15-Aug-2023. First documented stock forecast 30-Aug-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1.11
$-0.19 (-14.62%)
2 years 2 months 13 days ago
(15-Aug-2023)
0/7 (0%)
$-0.18 (-13.95%)
Hold
$16
2 years 2 months 14 days ago
(14-Aug-2023)
2/5 (40%)
$3.93 (32.56%)
52
Buy
$8
$6.7 (515.38%)
$8
4 years 5 months 23 days ago
(05-May-2021)
2/9 (22.22%)
$3.99 (99.50%)
113
Buy
$7.25
$5.95 (457.69%)
$8.5
4 years 7 months 19 days ago
(09-Mar-2021)
1/4 (25%)
$2.91 (67.05%)
225
Buy
$9
$7.7 (592.31%)
$12
4 years 10 months 8 days ago
(20-Dec-2020)
0/5 (0%)
$5.56 (161.63%)
What is ZYNE (Zynerba Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ZYNE (Zynerba Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ZYNE (Zynerba Pharmaceuticals)?
Which analyst is the currently most bullish on ZYNE (Zynerba Pharmaceuticals)?
Which analyst is the currently most reserved on ZYNE (Zynerba Pharmaceuticals)?
